These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35916497)

  • 1. Platelet-Inspired Intravenous Nanomedicine for Injury-Targeted Direct Delivery of Thrombin to Augment Hemostasis in Coagulopathies.
    Girish A; Jolly K; Alsaadi N; de la Fuente M; Recchione A; An R; Disharoon D; Secunda Z; Raghunathan S; Luc NF; Desai C; Knauss E; Han X; Hu K; Wang H; Sekhon UDS; Rohner N; Gurkan UA; Nieman M; Neal MD; Sen Gupta A
    ACS Nano; 2022 Oct; 16(10):16292-16313. PubMed ID: 35916497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.
    Shukla M; Sekhon UD; Betapudi V; Li W; Hickman DA; Pawlowski CL; Dyer MR; Neal MD; McCrae KR; Sen Gupta A
    J Thromb Haemost; 2017 Feb; 15(2):375-387. PubMed ID: 27925685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
    Diamond SL
    Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.
    Adili R; Jackson M; Stanger L; Dai X; Li M; Li BX; Holinstat M
    Clin Appl Thromb Hemost; 2021; 27():10760296211018510. PubMed ID: 34047195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport physics and biorheology in the setting of hemostasis and thrombosis.
    Brass LF; Diamond SL
    J Thromb Haemost; 2016 May; 14(5):906-17. PubMed ID: 26848552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Strategies for Engineering Intravenous Hemostats.
    Chan LW; White NJ; Pun SH
    Bioconjug Chem; 2015 Jul; 26(7):1224-36. PubMed ID: 25803791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
    MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R
    J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro.
    Thomas KA; Shea SM; Spinella PC
    Transfusion; 2021 Jun; 61(6):1943-1954. PubMed ID: 33755208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.
    Raghunathan S; Rayes J; Sen Gupta A
    J Thromb Haemost; 2022 Jul; 20(7):1535-1549. PubMed ID: 35435322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and regulation of platelet and fibrin hemostatic plug.
    Hawiger J
    Hum Pathol; 1987 Feb; 18(2):111-22. PubMed ID: 3804319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wound-triggered shape change microgels for the development of enhanced biomimetic function platelet-like particles.
    Chee E; Mihalko E; Nellenbach K; Sollinger J; Huang K; Hon M; Pandit S; Cheng K; Brown A
    J Biomed Mater Res A; 2024 Apr; 112(4):613-624. PubMed ID: 37846887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
    Matonick JP; Hammond J
    J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trauma patients have reduced ex vivo flow-dependent platelet hemostatic capacity in a microfluidic model of vessel injury.
    Thomas KA; Rassam RMG; Kar R; Dishong DM; Rahn KC; Fonseca R; Canas M; Aldana J; Afzal H; Bochicchio K; Neal MD; Bochicchio GV; Spinella PC; Shea SM
    PLoS One; 2024; 19(7):e0304231. PubMed ID: 38985805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma.
    Tanaka KA; Terada R; Butt AL; Mazzeffi MA; McNeil JS
    Anesth Analg; 2023 May; 136(5):894-904. PubMed ID: 37058725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII.
    Demers M; Aleman MM; Kistanova E; Peters R; Salas J; Seth Chhabra E
    J Thromb Haemost; 2022 Jul; 20(7):1674-1683. PubMed ID: 35466511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.